The Oncomine™ Comprehensive DNA Assay This is a targeted, multi-biomarker assay that enables simultaneous detection of thousands of variants across 148 genes relevant to solid tumours using DNA sequencing. The Oncomine™ Comprehensive RNA Assay (OCP22) uses RNA sequencing to detect gene fusions in 22 genes. The panel has been designed for translational and clinical research … Continue reading Oncomine Comprehensive Targeted Sequencing of DNA and RNA in Cancer
Copy and paste this URL into your WordPress site to embed
Oncomine Comprehensive Targeted Sequencing of DNA and RNA in Cancer
The Oncomine™ Comprehensive DNA Assay This is a targeted, multi-biomarker assay that enables simultaneous detection of thousands of variants across 148 genes relevant to solid tumours using DNA sequencing. The Oncomine™ Comprehensive RNA Assay (OCP22) uses RNA sequencing to detect gene fusions in 22 genes. The panel has been designed for translational and clinical research … Continue reading Oncomine Comprehensive Targeted Sequencing of DNA and RNA in Cancer